Angio-Proteomie is a private-owned biotech company, actively engaged in developing research reagents for Life Science R & D fields. We are known to offer high-quality antibodies, human primary cells, and cell lines, particularly those with GFP or RFP tagged cells for 3D models and imaging. Meanwhile, Angio-Proteomie, is at its early stage to develop therapeutic whole human antibody using human B cell hybridoma approach.